Glucotrack, Inc.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
GCTK$1.39-32.2%Stored close · as of Oct 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands of US Dollars)
| Six-month period ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| (Unaudited) | ||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Loss for the period | $(8,148) | $(11,589) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 43 | 19 |
| Stock-based compensation | 120 | 80 |
| Amortization of original issue discount related to promissory note | 298 | - |
| Loss on extinguishment of debt | 266 | - |
| Change in fair value of derivative liability | (1) | 3,269 |
| Amortization of debt discount and interest expense related to promissory notes | - | 5 |
| Loss on warrant repurchase | - | 95 |
| Changes in assets and liabilities: | ||
| Other current assets | 27 | (371) |
| Accounts payable | (201) | 1,652 |
| Other current liabilities | (68) | 157 |
| Net cash used in operating activities | (7,664) | (6,683) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of property and equipment | - | (9) |
| Net cash used in investing activities | - | (9) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Net proceeds from exercise of pre-funded warrants | 1 | - |
| Net proceeds from ELOC financing | 1,692 | - |
| Payment of promissory note | (299) | |
| Net proceeds from underwritten U.S. public offerings | - | 10,715 |
| Series A warrant repurchase | - | (160) |
| Net cash provided by financing activities | 1,394 | 10,555 |
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash | 11 | 65 |
| Change in cash and cash equivalents, and restricted cash | (6,259) | 3,928 |
| Cash and cash equivalents, and restricted cash at beginning of the period | 7,383 | 5,627 |
| Cash and cash equivalents, and restricted cash, end of period | $1,124 | $9,555 |
| Six-month period ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| (Unaudited) | ||
| Supplemental disclosure of cash flow activities: | ||
| (a) Net cash paid during the quarter for: | ||
| Interest | $15 | $81 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.